Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Gurin Full Text
European Urology, 06/20/2012
Palou J et al. – In primary T1G3 bladder tumours treated with induction bacillus Calmette–Guerin, female gender or having carcinoma in situ in the prostatic urethra were the only prognostic factors for time to recurrence, progression, and disease–related mortality. It is very important to perform a biopsy of the prostatic urethra in patients with primary high–grade non–muscle–invasive bladder cancer as a first step to obtain this prognostic information.